Literature DB >> 35231560

Connectomic-genetic signatures in the cerebral small vessel disease.

Raquel Gutiérrez-Zúñiga1, Ibai Diez2, Elisenda Bueichekú3, Chan-Mi Kim3, William Orwig2, Victor Montal4, Blanca Fuentes5, Exuperio Díez-Tejedor5, Maria Gutiérrez Fernández5, Jorge Sepulcre6.   

Abstract

Small vessel disease (SVD) is a disorder that causes vascular lesions in the entire parenchyma of the human brain. At present, it is not well understood how primary and secondary damage interact to give rise to the complex scenario of white matter (WM) and grey matter (GM) lesions. Using novel cross-sectional and longitudinal connectomic approaches, we unveil the bidirectional nature of GM and WM changes, that is, primary cortical neurodegeneration that leads to secondary alterations in vascular border zones, and WM lesions that lead to secondary neurodegeneration in cortical projecting areas. We found this GM-WM interaction to be essential for executive cognitive performance. Moreover, we also observed that the interlocked degeneration of GM and WM over time associates with prototypical expression levels of genes potentially linked to SVD. Among these connectomic-genetic intersections, we found that the Androgen Receptor (AR) gene, is a particularly central candidate gene that might confer key vulnerability for brain lesion development in SVD. In conclusion, this study advances in the understanding of the bidirectional relationships between GM and WM lesions, primary and secondary vascular neurodegeneration, and sheds light on the genetic signatures of SVD.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Connectomics; Genetics; Graph Theory; Grey matter; Neurodegeneration; Small vessel disease; White matter

Mesh:

Year:  2022        PMID: 35231560      PMCID: PMC8957615          DOI: 10.1016/j.nbd.2022.105671

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  56 in total

1.  Development of White Matter Hyperintensity Is Preceded by Reduced Cerebrovascular Reactivity.

Authors:  Kevin Sam; Adrian P Crawley; John Conklin; Julien Poublanc; Olivia Sobczyk; Daniel M Mandell; Lakshmikumar Venkatraghavan; James Duffin; Joseph A Fisher; Sandra E Black; David J Mikulis
Journal:  Ann Neurol       Date:  2016-08       Impact factor: 10.422

2.  White matter hyperintensities and imaging patterns of brain ageing in the general population.

Authors:  Mohamad Habes; Guray Erus; Jon B Toledo; Tianhao Zhang; Nick Bryan; Lenore J Launer; Yves Rosseel; Deborah Janowitz; Jimit Doshi; Sandra Van der Auwera; Bettina von Sarnowski; Katrin Hegenscheid; Norbert Hosten; Georg Homuth; Henry Völzke; Ulf Schminke; Wolfgang Hoffmann; Hans J Grabe; Christos Davatzikos
Journal:  Brain       Date:  2016-02-24       Impact factor: 13.501

3.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

4.  Brain circuit-gene expression relationships and neuroplasticity of multisensory cortices in blind children.

Authors:  Laura Ortiz-Terán; Ibai Diez; Tomás Ortiz; David L Perez; Jose Ignacio Aragón; Victor Costumero; Alvaro Pascual-Leone; Georges El Fakhri; Jorge Sepulcre
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

Review 5.  Vascular dementia.

Authors:  John T O'Brien; Alan Thomas
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

6.  The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing.

Authors:  Meredith A Shafto; Lorraine K Tyler; Marie Dixon; Jason R Taylor; James B Rowe; Rhodri Cusack; Andrew J Calder; William D Marslen-Wilson; John Duncan; Tim Dalgleish; Richard N Henson; Carol Brayne; Fiona E Matthews
Journal:  BMC Neurol       Date:  2014-10-14       Impact factor: 2.474

Review 7.  Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management.

Authors:  Laura Ramiro; Alba Simats; Teresa García-Berrocoso; Joan Montaner
Journal:  Ther Adv Neurol Disord       Date:  2018-08-06       Impact factor: 6.570

8.  The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats.

Authors:  Solveig Jandke; Cornelia Garz; Daniel Schwanke; Michael Sendtner; Hans-Jochen Heinze; Roxana O Carare; Stefanie Schreiber
Journal:  Brain Pathol       Date:  2018-10-10       Impact factor: 6.508

9.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

10.  Neurogenetic profiles delineate large-scale connectivity dynamics of the human brain.

Authors:  Ibai Diez; Jorge Sepulcre
Journal:  Nat Commun       Date:  2018-09-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.